MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions
View by Date

Saturday, October 6, 2018

1:45pm-3:15pm
Levodopa effect on non-motor symptoms in late stage Parkinson’s disease

K. Rosqvist, P. Odin, P. Hagell, S. Iwarsson, M. Nilsson, A. Storch (Lund, Sweden)

Clinical Trials and Therapy in Movement Disorders  ·  Hall 3FG
1:45pm-3:15pm
Levodopa induced dyskinesia is preventable (15 years experience using continuous dopaminergic stimulation)

M. Lin, R. Laureno (Washington, DC, USA)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
1:45pm-3:15pm
Levodopa Induced Orthostatic Hypotension in Parkinson’s Disease: A Single-Dose Response Study

K. Thiankhaw, S. Tanprawate, A. Soontornpun, A. Nudsasarn, S. Chankrachang (Chiang Mai, Thailand)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
1:45pm-3:15pm
Levosulpiride Induced Movement Disorder: 7 cases

D. Radhakrishnan, V. Goyal (New Delhi, India)

Drug-Induced Movement Disorders  ·  Hall 3FG
1:45pm-3:15pm
Lewy body disease with visual hallucination: Optic radiation abnormalities on phase difference-enhanced imaging (PADRE)

M. Miyata, S. Kakeda, T. Yoneda, K. Okada, H. Adachi, Y. Korogi (Kitakyushu, Japan)

Neuroimaging (Non-PD)  ·  Hall 3FG
1:45pm-3:15pm
Linking neuroplastic effects to behavioral changes after balance training in Parkinson’s disease: a study protocol of a randomized controlled trial

E. Franzén, H. Johansson, M. Freidle, U. Ekman, E. Schalling, A. Lebedev, M. Lövdén, S. Holmin, P. Svenningsson, M. Hagströmer (Huddinge, Sweden)

Clinical Trials and Therapy in Movement Disorders  ·  Hall 3FG
1:45pm-3:15pm
Liquid sinemet in the management of complex motor fluctuations in advanced Parkinson’s Disease

C. Sung, M. Danoudis, R. Iansek (Melbourne, Australia)

Parkinson’s Disease: Clinical Trials, Pharmacology And Treatment  ·  Hall 3FG
1:45pm-3:15pm
Long term clinical outcome after deep brain stimulation of the thalamic VIM in Holmes Tremor: A case series

J. Becktepe, S. Paschen, F. Goevert, A. Helmers, G. Deuschl (Kiel, Germany)

Surgical Therapy: Other Movement Disorders  ·  Hall 3FG
1:45pm-3:15pm
Long Term Outcome of the Subthalamic Nucleus DBS for Advanced Parkinson’s Disease: An Eight Years Follow-Up Study in China

Q. Guo, J. Liu, C. Yang, W. Xian, L. Jiang, S. Xu, W. Chen, Y. Hu, L. Chen (Guangzhou, China)

Surgical Therapy: Parkinson's Disease  ·  Hall 3FG
1:45pm-3:15pm
Long Term Response to L-dopa in Parkinson Disease

H. Gupta, N. Wachter, K. Lyons, R. Pahwa (Kansas, KS, USA)

Neuropharmacology  ·  Hall 3FG
  • «Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 59
  • Next Page»

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley